Xujiang Xie's bloodletting therapy combined with Qingyan Lige decoction for acute pharyngitis with lung-stomach heat accumulation: a randomized controlled trial.
10.13703/j.0255-2930.20241120-0001
- Author:
Xinhua FAN
1
;
Minfang YUAN
2
;
Guohua LI
1
;
Tingting KANG
1
;
Peiling LI
1
;
Qiang XIE
3
Author Information
1. Department of Otorhinolaryngology, Tongxiang Hospital of TCM, Tongxiang 314500, Zhejiang Province, China.
2. Department of Dermatology, Tongxiang Hospital of TCM, Tongxiang 314500, Zhejiang Province, China.
3. Department of Otorhinolaryngology, Jiangxi Provincial Hospital of TCM, Nanchang
- Publication Type:English Abstract
- Keywords:
Qingyan Lige decoction;
Xujiang Xie's bloodletting therapy;
acute pharyngitis, lung-stomach heat accumulation;
bloodletting therapy;
randomized controlled trial (RCT)
- MeSH:
Humans;
Drugs, Chinese Herbal/administration & dosage*;
Male;
Female;
Pharyngitis/drug therapy*;
Adult;
Middle Aged;
Bloodletting;
Young Adult;
Lung/drug effects*;
Combined Modality Therapy;
Interleukin-6;
Adolescent;
Tumor Necrosis Factor-alpha;
Acute Disease/therapy*;
Treatment Outcome
- From:
Chinese Acupuncture & Moxibustion
2025;45(11):1565-1570
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the clinical efficacy of Xujiang Xie's bloodletting therapy combined with Qingyan Lige decoction on acute pharyngitis with lung-stomach heat accumulation.
METHODS:A total of 88 patients with acute pharyngitis of lung-stomach heat accumulation were randomly divided into an observation group (44 cases, 4 cases dropped out) and a control group (44 cases, 4 cases dropped out). The control group was treated with oral Qingyan Lige decoction, 150 mL each time, twice a day for 6 continuous days. On the basis of the treatment in the control group, Xujiang Xie's bloodletting therapy was applied at bilateral Shaoshang (LU11), Shangyang (LI1), and Erjian (EX-HN6) in the observation group, 0.1-0.5 mL of bloodletting per site, once every other day for 3 times in total. The TCM symptom and sign score, complete blood count (white blood cell [WBC] count, neutrophilic granulocyte percentage [NE%]), inflammation indexes (serum levels of C-reactive protein[CRP], interleukin[IL]-1β, IL-6, tumor necrosis factor [TNF]-α) and immune indexes (？？, ？？, ？？) of the two groups were observed before treatment and after 6 days of treatment, and the clinical efficacy was evaluated.
RESULTS:After 6 days of treatment, the sore throat scores, redness and swelling scores of pharyngeal mucosa and uvula, pharyngeal dry and burning scores, hyperemia scores of posterior pharyngeal lymphoid follicles, chill and fever scores, total scores of TCM symptom and sign, WBC count, NE%, CRP, IL-1β, IL-6, TNF-α and ？？ in both groups were decreased compared with those before treatment (P<0.05), the above indexes in the observation group were lower than those in the control group (P<0.01, P<0.05, P<0.001). After 6 days of treatment, the levels of ？？ and ？？ in both groups were increased compared with those before treatment (P<0.05), and the above indexes in the observation group were higher than those in the control group (P<0.001). The total effective rate of the observation group was 95.0% (38/40), which was higher than 90.0% (36/40) in the control group (P<0.001).
CONCLUSION:Xujiang Xie's bloodletting therapy combined with Qingyan Lige decoction could improve the symptoms in patients with acute pharyngitis of lung-stomach heat accumulation, inhibit inflammatory response and improve immune function.
